Our Services
Medical Information
Helpful Resources
Published on: 4/13/2026
Insomnia is common after starting an SSRI due to serotonin’s activating effects, disrupted melatonin production, and dose timing issues, typically peaking in the first two weeks and improving by six weeks in most people. However, if sleep disturbances persist beyond this period or worsen, it’s important to review treatment options with your doctor.
There are several strategies—from shifting your dose to morning dosing and enhancing sleep hygiene to considering adjunct low-dose sleep aids—that can help bridge this gap. See below for a complete breakdown of causes, timelines, management tips, and when to seek further help.
It's not unusual to experience insomnia after starting an SSRI (selective serotonin reuptake inhibitor). Many people begin these medications hoping for relief from depression or anxiety, only to find themselves lying awake at night. Understanding why this happens, how long it may last, and what you can do about it can help you stay on track with your treatment and protect your sleep.
SSRIs work by increasing serotonin levels in the brain, which can improve mood and reduce anxiety. However, changes in brain chemistry can also affect your sleep cycle. Key factors include:
Activation effect
Early in treatment, raised serotonin can be stimulating. You may feel more alert or jittery, making it harder to fall asleep.
Melatonin interference
Serotonin is a precursor to melatonin, the hormone that regulates sleep. SSRIs can throw off your melatonin production, shifting your sleep–wake rhythm.
Dose timing
Taking your dose later in the day may overlap with your natural wind-down period, making it tough to nod off.
Individual sensitivity
Everyone's brain chemistry is unique. Some people tolerate SSRIs with no sleep changes, while others find them very activating.
According to guidelines from the American Academy of Sleep Medicine and research in the Journal of Clinical Psychiatry, these sleep disruptions often appear within the first one to two weeks of SSRI treatment and may improve over time.
Insomnia can look different from person to person. Common signs include:
If you notice any of these symptoms after beginning an SSRI, it's likely related to the medication—especially if your sleep was stable before.
First 1–2 weeks
Sleep disruption often peaks in this window. Your body is adjusting to higher serotonin levels.
Weeks 3–6
Many people see sleep begin to normalize as the body adapts.
After 6 weeks
Persistent insomnia beyond this point may need a closer look by your doctor. At that stage, strategies like dose adjustment or adding a low-dose sleep aid could be discussed.
Keep in mind: every person's timeline is different. If sleep doesn't improve or worsens after six weeks, it's time to re-evaluate with your provider.
Review Your Medication Routine
Optimize Sleep Hygiene
Monitor Stimulant Intake
Practice Relaxation Techniques
Consider Natural Sleep Aids (Under Doctor Supervision)
Talk About Adjunct Medications
If insomnia persists, your doctor may suggest:
While mild sleep disturbances can be normal, certain signs merit prompt attention:
If you're experiencing any concerning symptoms or want to better understand what you're going through, consider using Ubie's free AI-powered symptom checker for those currently on antidepressants. This tool can help you document your symptoms and generate a personalized report to share with your healthcare provider, making your next appointment more productive.
Insomnia after starting an SSRI can be frustrating, but it often improves as your body adapts. By optimizing your sleep habits, adjusting medication timing, and seeking professional guidance when needed, you can bridge the gap and maintain your mental health journey.
Always remember: if you experience any serious or life-threatening symptoms—especially thoughts of self-harm—reach out to a doctor or emergency services immediately. Speak to your healthcare provider before making any changes to your medication or sleep regimen. Your safety and well-being come first.
(References)
* Pompili M, et al. Pharmacological Management of Antidepressant-Induced Insomnia: A Narrative Review. Front Psychiatry. 2021 May 26;12:658661. doi: 10.3389/fpsyt.2021.658661. PMID: 34122340; PMCID: PMC8187216.
* Wichniak A, et al. Sleep-wake cycle disturbances in depression: impact of antidepressants. Pharmacol Rep. 2017 Dec;69(6):1187-1195. doi: 10.1016/j.pharep.2017.06.012. Epub 2017 Jul 20. PMID: 29112999.
* D'Andrea G, et al. Antidepressant Treatment and Sleep Architecture: An Overview of the Effects of First-Line Antidepressant Classes on Sleep Architecture. CNS Neurol Disord Drug Targets. 2022 Dec 22. doi: 10.2174/1871527322666221222105101. PMID: 36565158.
* Wilson S. Sleep dysfunction and antidepressant treatment: A patient's perspective. Dialogues Clin Neurosci. 2017 Dec;19(4):379-386. doi: 10.31887/DCNS.2017.19.4/swilson. PMID: 29339943; PMCID: PMC5751093.
* Putilov AA, et al. Systematic review of the effects of antidepressant drugs on sleep. J Psychiatr Res. 2023 Apr;161:46-57. doi: 10.1016/j.jpsychires.2023.02.016. Epub 2023 Feb 21. PMID: 36848777.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.